|
1
|
Teicher BA: CD248: A therapeutic target in
cancer and fibrotic diseases. Oncotarget. 10:993–1009. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Christian S, Ahorn H, Koehler A,
Eisenhaber F, Rodi H-P, Garin-Chesa P, Park JE, Rettig WJ and
Lenter MC: Molecular cloning and characterization of endosialin, a
C-type lectin-like cell surface receptor of tumor endothelium. J
Biol Chem. 276:7408–7414. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Viski C, König C, Kijewska M, Mogler C,
Isacke CM and Augustin HG: Endosialin-Expressing Pericytes Promote
Metastatic Dissemination. Cancer Res. 76:5313–5325. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tomkowicz B, Rybinski K, Foley B, Ebel W,
Kline B, Routhier E, Sass P, Nicolaides NC, Grasso L and Zhou Y:
Interaction of endosialin/TEM1 with extracellular matrix proteins
mediates cell adhesion and migration. Proc Natl Acad Sci USA.
104:17965–17970. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun D-X, Liao G-J, Liu K-G and Jian H:
Endosialin expressing bone sarcoma stem like cells are highly tumor
initiating and invasive. Mol Med Rep. 12:5665–5670. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lange SE, Zheleznyak A, Studer M,
O'Shannessy DJ, Lapi SE and Van Tine BA: Development of
89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications.
Oncotarget. 7:13082–13092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rybinski K, Imtiyaz HZ, Mittica B,
Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q,
Kline B, et al: Targeting endosialin/CD248 through
antibody-mediated internalization results in impaired pericyte
maturation and dysfunctional tumor microvasculature. Oncotarget.
6:25429–25440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Diaz LA Jr, Coughlin CM, Weil SC, Fishel
J, Gounder MM, Lawrence S, Azad N, O'Shannessy DJ, Grasso L,
Wustner J, et al: A first-in-human phase I study of MORAb-004, a
monoclonal antibody to endosialin in patients with advanced solid
tumors. Clin Cancer Res. 21:1281–1288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones RL, Chawla SP, Attia S, Schöffski P,
Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC,
Patel S, et al: A phase 1 and randomized controlled phase 2 trial
of the safety and efficacy of the combination of gemcitabine and
docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue
sarcomas. Cancer. 125:2445–2454. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuniyasu H, Yasui W, Shinohara H, Yano S,
Ellis LM, Wilson MR, Bucana CD, Rikita T, Tahara E and Fidler IJ:
Induction of angiogenesis by hyperplastic colonic mucosa adjacent
to colon cancer. Am J Pathol. 157:1523–1535. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bagley RG, Rouleau C, St Martin T, Boutin
P, Weber W, Ruzek M, Honma N, Nacht M, Shankara S, Kataoka S, et
al: Human endothelial precursor cells express tumor endothelial
marker 1/endosialin/CD248. Mol Cancer Ther. 7:2536–2546. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tanabe E, Kitayoshi M, Fujii K, Ohmori H,
Luo Y, Kadochi Y, Mori S, Fujiwara R, Nishiguchi Y, Sasaki T, et
al: Fatty acids inhibit anticancer effects of 5-fluorouracil in
mouse cancer cell lines. Oncol Lett. 14:681–686. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Qiu RL, Lin Y, Cai Y, Bian Y, Fan Y
and Gao XJ: Resveratrol suppresses human cervical carcinoma cell
proliferation and elevates apoptosis via the mitochondrial and p53
signaling pathways. Oncol Lett. 15:9845–9851. 2018.PubMed/NCBI
|
|
15
|
Kishi S, Fujiwara-Tani R, Luo Y, Kawahara
I, Goto K, Fujii K, Ohmori H, Nakashima C, Sasaki T and Kuniyasu H:
Pro-metastatic signaling of the trans fatty acid elaidic acid is
associated with lipid rafts. Oncol Lett. 15:4423–4426.
2018.PubMed/NCBI
|
|
16
|
Luo Y, Fujii K, Ohmori H, Sasahira T,
Moriwaka Y, Isobe M and Kuniyasu H: Antisense phosphorothioate
oligodeoxynucleic acid for CD10 suppresses liver metastasis of
colorectal cancer. Pathobiology. 76:267–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van der Meer AD, Vermeul K, Poot AA,
Feijen J and Vermes I: A microfluidic wound-healing assay for
quantifying endothelial cell migration. Am J Physiol Heart Circ
Physiol. 298:H719–H725. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suarez-Arnedo A, Torres Figueroa F,
Clavijo C, Arbeláez P, Cruz JC and Muñoz-Camargo C: An image J
plugin for the high throughput image analysis of in vitro scratch
wound healing assays. PLoS One. 15:e02325652020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lindsey BA, Markel JE and Kleinerman ES:
Osteosarcoma Overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Broadhead ML, Clark JCM, Myers DE, Dass CR
and Choong PFM: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nanda A, Karim B, Peng Z, Liu G, Qiu W,
Gan C, Vogelstein B, St Croix B, Kinzler KW and Huso DL: Tumor
endothelial marker 1 (Tem1) functions in the growth and progression
of abdominal tumors. Proc Natl Acad Sci USA. 103:3351–3356. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tomkowicz B, Rybinski K, Sebeck D, Sass P,
Nicolaides NC, Grasso L and Zhou Y: Endosialin/TEM-1/CD248
regulates pericyte proliferation through PDGF receptor signaling.
Cancer Biol Ther. 9:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
